Taiwan has given emergency use authorization (EUA) to a COVID-19 vaccine developed by Taiwan-based Medigen Vaccine Biologics Corp. after a panel of experts felt its data on the vaccine's production of antibodies in Phase 2 trials met local standards.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Cabinet to strengthen vetting of civil servants amid espionage probes
04/17/2025 04:01 PM - Business
TSMC reports highest-ever Q1 net profits
04/17/2025 03:08 PM - Business
U.S.' new chip sanctions will hurt Taiwan suppliers: Analysts
04/17/2025 02:53 PM - Culture
Wanhua festival gives Taiwanese dance global stage
04/17/2025 02:42 PM - Business
Taiwan shares close down 0.66%
04/17/2025 02:01 PM